Artivion, Inc.
AORT- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000784199
In the last 90 days, Artivion, Inc. insiders filed 0 open-market purchases and 6 sales; 206 institutions reported holding it in 13F filings for Q2 2026, worth $1.03B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Artivion, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 6 filings
- 4 insiders, $2.60M in total
- Insiders trading
- 4
- Net value
- −$2.60M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Artivion, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Green Andrew M | SVP, Regulatory and Quality | 40,160 | Sep 11, 2026 | 4 |
| Mackin James P | President & CEO | 877,275 | Aug 20, 2026 | 8 |
| Berry Lance A | EVP, COO, CFO & Treasurer | 210,112 | Aug 17, 2026 | 4 |
| Holloway Jean F | SVP, General Counsel | 184,118 | Aug 12, 2026 | 8 |
| Semedo Anthony B. | Director | 6,325Indirect | Jun 4, 2026 | 2 |
| Ackerman Thomas F | Director | 157,472 | May 20, 2026 | 1 |
| Bullock James | Director | 76,223 | May 20, 2026 | 1 |
| Bevevino Daniel J | Director | 157,637 | May 20, 2026 | 1 |
| Burbank Jeffrey H | Director | 61,372 | May 20, 2026 | 1 |
| Salveson Jon W | Director | 137,416 | May 20, 2026 | 1 |
| Borgstrom Marna P | Director | 56,664 | May 20, 2026 | 1 |
| Hoff Elizabeth A | Director | 34,765 | May 20, 2026 | 2 |
| Horton Amy | VP, Chief Accounting Officer | 139,088 | Mar 4, 2026 | 8 |
| Davis John E | Chief Commercial Officer | 230,794 | Mar 4, 2026 | 7 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 60,097 | Mar 4, 2026 | 7 |
| Getz Matthew A | VP, Human Resources | 34,116 | Aug 19, 2024 | 0 |
| Maney Rochelle L. | VP, Quality | 44,518 | Mar 14, 2024 | 0 |
| Tyrs Florian | VP, Global Operations | 21,558 | Feb 29, 2024 | 0 |
| Thomson Robert C | VP Research & Development | 13,291 | Feb 26, 2024 | 0 |
| Maier Dennis B | SVP, Operations | 34,724 | Jun 8, 2023 | 0 |
| Lee David Ashley | Executive VP, COO & CFO | 347,217 | Mar 3, 2023 | 0 |
| Barthold Franz Peter | VP, Research & Development | 32,516 | Nov 10, 2022 | 0 |
| Morgan Harvey | Director | 46,342Indirect | Aug 31, 2021 | 0 |
| McCall Ronald D | Director | 121,768 | Aug 26, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2023 (view filing) | Feb 14 | 2 days | Mackin James PPresident & CEO | SSale | −56.5K | $13.22 | −$746.9K | −10.1%505.7K after | |
| Dec 16, 2022 (view filing) | Dec 14 | 2 days | Horton AmyVP, Chief Accounting Officer | SSale | −3.23K | $13.57 | −$43.8K | −3.1%102.0K after | |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Maney Rochelle L.VP, Quality | SSale | −7.16K | $22.96 | −$164.4K | −36.7%12.3K after | |
| Aug 10, 2022 (view filing) | Aug 9 | 1 day | Maier Dennis BSVP, Operations | SSale | −5.76K | $21.61 | −$124.5K | −20.2%22.8K after | 5 lots |
| Feb 11, 2022 (view filing) | Feb 9-10 | 2 days | Mackin James PPresident & CEO | SSale | −21.3K | $18.00 | −$383.0K | −6.5%304.2K after | 2 lots |
| Feb 10, 2022 (view filing) | Feb 8 | 2 days | Mackin James PPresident & CEO | SSale | −10.6K | $17.75 | −$188.8K | −3.4%304.2K after | |
| Feb 8, 2022 (view filing) | Feb 7 | 1 day | Mackin James PPresident & CEO | SSale | −10.6K | $17.30 | −$184.0K | −3.4%304.2K after | |
| Dec 10, 2021 (view filing) | Dec 8 | 2 days | Horton AmyVP, Chief Accounting Officer | SSale | −2.50K | $18.57 | −$46.4K | −2.8%86.8K after | |
| Dec 1, 2021 (view filing) | Nov 29 | 2 days | Davis John ESenior VP, Global Sales | PPurchase | +600 | $17.33 | +$10.4K | +0.8%72.5K after | |
| Nov 30, 2021 (view filing) | Nov 29 | 1 day | Semedo Anthony B.Director | PPurchase | +15.0K | $17.36 | +$260.4K | +300.5%20.0K after | |
| Sep 1, 2021 (view filing) | Aug 31 | 1 day | Holloway Jean FSVP, General Counsel | SSale | −663 | $26.49 | −$17.6K | −0.8%86.6K after | |
| Aug 26, 2021 (view filing) | Aug 25 | 1 day | McCall Ronald DDirector | SSale | −5.67K | $25.63 | −$145.2K | −4.4%121.8K after | |
| Aug 24, 2021 (view filing) | Aug 23 | 1 day | Maier Dennis BVice President, Operations | SSale | −2.71K | $25.64 | −$69.6K | −13.3%17.7K after |